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Brief Communications

Collapsin Response Mediator Protein 1 Mediates Reelin
Signaling in Cortical Neuronal Migration
Naoya Yamashita,1 Yutaka Uchida,1 Toshio Ohshima,4 Syu-ichi Hirai,2 Fumio Nakamura,1 Masahiko Taniguchi,5
Katsuhiko Mikoshiba,4 Jérôme Honnorat,6 Pappachan Kolattukudy,7 Nicole Thomasset,6 Kohtaro Takei,1,8
Takuya Takahashi,3 and Yoshio Goshima1,8
Departments of 1Molecular Pharmacology and Neurobiology, 2Molecular Biology, and 3Physiology and Neuroendocrinology, Yokohama City University
Graduate School of Medicine, Yokohama 236-0004, Japan, 4Laboratory for Developmental Neurobiology, Brain Science Institute, The Institute of Physical
and Chemical Research, Wako 351-0198, Japan, 5Department of Biochemistry, Cancer Research Institute, Sapporo Medical University, Sapporo 060-8556,
Japan, 6Institut National de la Santé et de la Recherche Médicale Unité 433, Institut Federatif des Neurosciences de Lyon, Hôpital Neurologique, F-69003
Lyon, France, 7Biomolecular Science Center, University of Central Florida, Biomolecular Science, Orlando, Florida 32816, and 8Core Research for
Evolutional Science and Technology, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan

Collapsin response mediator protein 1 (CRMP1) is one of the CRMP family members that mediates signal transduction of axon guidance
molecules. Here, we show evidence that CRMP1 is involved in Reelin (Reln) signaling to regulate neuronal migration in the cerebral
cortex. In crmp1⫺/⫺ mice, radial migration of cortical neurons was retarded. This phenotype was not observed in the sema3A⫺/⫺ and
crmp1⫹/⫺;sema3A⫹/⫺ cortices. However, CRMP1 was colocalized with disabled-1 (Dab1), an adaptor protein in Reln signaling. In the
Relnrl/rl cortex, CRMP1 and Dab1 were expressed at a higher level, yet tyrosine phosphorylated at a lower level. Loss of crmp1 in a dab1
heterozygous background led to the disruption of hippocampal lamination, a Reeler-like phenotype. In addition to axon guidance,
CRMP1 regulates neuronal migration by mediating Reln signaling.
Key words: CRMP; Reln; Dab1; tyrosine phosphorylation; neuronal migration; cerebral cortex

Introduction
The development of the neocortex has been of keen interest,
because the cortex is uniquely mammalian and forms the basis
for higher function. The neocortex consists of six layers of neurons that have distinct morphological and functional identities.
The development of these neuronal layers involves the migration
of neurons to their final laminar positions (Bielas et al., 2004).
Reelin (Reln) is a secreted protein that is involved in neuronal
migration (Lambert de Rouvroit and Goffinet, 1998). During
Reln binding to ApoER2/VLDLR receptors, the cytoplasmic
adaptor disabled-1 (Dab1) becomes phosphorylated on tyrosine
residues by Src-type tyrosine kinases (Hiesberger et al., 1999;
Howell et al., 1999a; Bock and Herz, 2003). Perinatal lethality
caused by widespread defects in neuronal migration during CNS
development is evident in mice deficient for cyclin-dependent
kinase 5 (Ohshima et al., 1996). Although how these molecules
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regulate neuronal migration remains obscure, several intracellular molecules, including Lis 1 (PAFAH1b1), doublecortin, Nudel,
microtubule associated protein (MAP)-1B, MAP-2, and the
small GTPase Rac1, have been implicated as mediators of these
molecules and are involved in cytoskeletal organization (Gupta et
al., 2002).
Collapsin response mediator protein (CRMP) was identified
as a signaling molecule of Sema3A (Goshima et al., 1995). CRMPs
are now known to be composed of five homologous cytosolic
proteins; all of the family proteins are phosphorylated and are
highly expressed in developing and adult nervous systems (Wang
and Strittmatter, 1996; Fukada et al., 2000; Inatome et al., 2000;
Yuasa-Kawada et al., 2003). CRMPs also mediate other signaling,
such as NT3, and are involved in many aspects of neuronal cell
development by regulating cytoskeletal organization (Goshima et
al., 1995, 2002; Quach et al., 2004; Arimura and Kaibuchi, 2005;
Uchida et al., 2005; Yoshimura et al., 2005). However, in vivo
roles of CRMPs are mostly unknown.
To elucidate in vivo roles of CRMP1 in the development of the
CNS, we have generated crmp1 ⫺ / ⫺ mice (Charrier et al., 2006).
We demonstrated that CRMP1 mediates Sema3A signaling in
vivo, which is involved in spine maturation (N. Yamashita, A.
Morita, Y. Uchida, F. Nakamura, H. Usui, M. Taniguchi, J. Honnorat, P. Kolattukudy, N. Thomasset, K. Takei, T. Takahashi, and
Y. Goshima, unpublished observations). Intense crmp1 expression is observed in the cerebral cortex at the embryonic day 16.5
(E16.5), the period of neuronal migration (Bielas et al., 2004). In
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the present study, we investigated whether CRMP1 plays a role in
neuronal migration in the cerebral cortex. We found that neuronal migration was retarded in the crmp1⫺/⫺ cerebral cortex. In
embryonic Relnrl/rl cortex, CRMP1 was tyrosine phosphorylated
at a lower level and expressed at a higher level when compared
with Relnrl/⫹. Furthermore, loss of crmp1 in a dab1 heterozygous
background led to the disruption of hippocampal lamination, a
Reeler-like phenotype. We propose that CRMP1 is involved in
radial neuronal migration through Reln signaling.

Materials and Methods
Materials. 5-Bromo-2⬘-deoxyuridine (BrdU) was purchased from GE
Healthcare (Piscataway, NJ). Anti-Dab1 (B3; rabbit polyclonal) antibody
was a kind gift from B. Howell (National Institute of Neurological Disorders and Stroke, Bethesda, MD). Monoclonal antibodies against
CRMP1 (2C6G and 2E7G) were raised as described previously (N. Yamashita, A. Morita, Y. Uchida, F. Nakamura, H. Usui, M. Taniguchi, J.
Honnorat, P. Kolattukudy, N. Thomasset, K. Takei, T. Takahashi, and Y.
Goshima, unpublished observations). Other antibodies used were antiBrdU (mouse monoclonal; MBL, Nagoya, Japan), anti-␤-actin (mouse
monoclonal; Sigma, St. Louis, MO), anti-Myc (9E10; mouse monoclonal; Sigma), anti-MAP-2 (2a ⫹ 2b) (mouse monoclonal; Sigma), antiNestin (mouse monoclonal; Chemicon, Temecula, CA), anti-p-Tyr
(PY99; mouse monoclonal; Santa Cruz Biotechnology, Santa Cruz, CA),
Cy3-labeled goat anti-Armenian hamster (Jackson ImmunoResearch,
West Grove, PA), and Alexa 488-labeled goat anti-rabbit (Invitrogen,
Cergy Pontoise, France).
Mutant mice. reeler B6C3Fe mice were from The Jackson Laboratory
(Bar Harbor, ME). yotari mice were spontaneous mutants at the dab1
allele (Yoneshima et al., 1997). sema3A and crmp1 mutant mice were
generated as described previously (Taniguchi et al., 1997; Charrier et al.,
2006). Genotypes of the offspring of all mutant mice were assessed using
PCR, as described previously (D’Arcangelo et al., 1997; Kojima et al.,
2000; Sasaki et al., 2002; Charrier et al., 2006). Mice were housed in the
standard mouse facility and fed with an autoclaved diet and water. All
procedures were performed according to the guidelines outlined by the
institutional Animal Care and Use Committee of the Yokohama City
University Graduate School of Medicine. Throughout the experimental
procedures, all efforts were made to minimize the number of animals
used and their suffering.
Immunoblot analysis and immunoprecipitation. Brain samples were
homogenized in immunoprecipitation (IP) buffer [20 mM Tris-HCl, pH
8.0, 150 mM NaCl, 1 mM EDTA, 10 mM NaF, 1 mM Na3VO4, 1% Nonidet
P-40, 50 M -APMSF (-amidinophenylmethanesulfonyl fluoride), and
10 g/ml of aprotinin]. The lysates were centrifuged at 1200 rpm for 15
min at 4°C, and supernatants were normalized for total protein concentrations. The samples were then used for immunoblot analysis of antiCRMP1 (2E7G; 1:2500), anti-␤-actin (1:5000), anti-Dab1 (1:500), antiMAP-2 (2a ⫹ 2b) (1:2000), and anti-Nestin (1:1000) antibodies. To
detect the tyrosine phosphorylation of CRMP1, the samples were incubated with 1 g of anti-CRMP1 (2E7G) antibody overnight at 4°C, followed by additional incubation with protein G–Sepharose (GE Healthcare) for 2 h at 4°C. After washing three times with IP buffer, the samples
were used for immunoblot analysis of anti-CRMP1 (2E7G) and anti-pTyr (1:5000) antibodies.
In vivo phosphorylation assay. HEK293T cells were seeded at 2.0 ⫻ 10 5
cells/well in a six-well plate. One day later, the cells were transfected with
CRMP1-Myc with or without the wild-type, constitutive-active or
dominant-negative form of Fyn expression vector using Fugene6 transfection reagent (Roche, Meylan, France). After 24 h, cells were lysed by IP
buffer and then immunoprecipitated with 1 g of anti-Myc antibody.
The samples were used for immunoblot analysis of anti-Myc (1:2500)
and anti-p-Tyr antibodies.
Immunohistochemistry. Cryostat brain sections (15 m thick) were
treated with 0.1% Triton X-100 in TBS with Tween 20 (TBST) for 10 min
at room temperature. Immunostaining was performed according to
standard protocols using anti-CRMP1 (2C6G; 1:1000) and anti-Dab1
(1:100) antibodies. Hydrolyzed, paraffin wax-embedded sections (6 m

thick) were used for immunohistochemistry of anti-MAP-2 (2a ⫹ 2b)
(1:200) and anti-Nestin (1:100) antibodies. Slides were analyzed using a
laser-scanning microscope (LSM510) with a water-immersed objective
at 40⫻ (C-Apochromat/1.2W corr) equipped with an Axioplan 2 imaging microscope (Carl Zeiss, Jena, Germany).
BrdU-labeling analysis. For birth-dating analysis, cells were labeled
with BrdU (30 mg/kg) in the E14.5 or E16.5 neocortical wall. Pups were
killed at E18.5, postnatal day 3 (P3) or P10, and brains were fixed in 4%
paraformaldehyde for paraffin wax-embedded sectioning. Hydrolyzed,
paraffin wax-embedded sections (6 m thick) were heat-treated at 120°C
for 20 min in 10 mM sodium citrate buffer, pH 6.0. Sections were then
treated with 0.1% Triton X-100 in TBST for 10 min and with 1.5N HCl
for 30 min at room temperature. Immunostaining was performed according to standard protocols using anti-BrdU antibody (1:1000). Slides
were analyzed using Olympus (Tokyo, Japan) IX-71 microscopy using a
10⫻ objective. For quantitative measurements, comparable sections
were chosen at the somatosensory cortex, which was divided into 10
horizontal bins from the superficial to the deep, and labeled nuclei in
each bin were counted (Teng et al., 2001).
Statistical significance. Data are shown as mean ⫾ SEM. The statistical
significance of the results was analyzed using a Student’s t test.

Results

Neuronal migration in crmp1⫺/⫺ cortex
To examine neuronal migration, we performed BrdU birthdating analysis in the crmp1⫺/⫺ cerebral cortex. In the brains of
P10 injected at E14.5 (P10 –BrdU–E14.5) crmp1 ⫹/ ⫺ cortex, most
labeled neurons were positioned in the deep layers of the cerebral
cortex destined to form layers IV and V. In crmp1 ⫺ / ⫺ mice, the
majority of labeled cells were positioned at layers IV and V. The
percentage of labeled cells positioned in those regions, however,
was decreased, and the percentage of other regions was increased
(Fig. 1 A). A similar phenotype was also observed in the P10 –
BrdU–E16.5 crmp1 ⫺ / ⫺ cortex. Most labeled neurons were positioned in the upper layers of the cortex, which were destined to
form layers II and III in crmp1 ⫹/ ⫺ cortex. However, the percentage of correctly positioned neurons was decreased, whereas the
percentage of the cells in the other regions tended to be increased
in crmp1⫺/⫺ mice (Fig. 1 B). We also investigated E18.5–BrdU–
E14.5 and P3–BrdU–E16.5 crmp1 ⫹/ ⫺ and crmp1 ⫺ / ⫺ mouse cortices to observe the radial migration. In both brains, the retarded
phenotype of neuronal migration was observed in the crmp1 ⫺ / ⫺
cortex (data not shown). We next investigated neuronal differentiation and survival in the crmp1 ⫺ / ⫺ cortex. At E16.5, apoptotic
cells were rarely observed by terminal deoxynucleotidyl
transferase-mediated biotinylated UTP nick end labeling staining. There was no difference in the proliferation of cortical progenitor cells between crmp1 ⫺ / ⫺ and crmp1 ⫹/ ⫺ cortices by BrdU
proliferative analysis (data not shown). Furthermore, immunoreactivity and protein expression levels of Nestin and MAP-2 (2a
⫹ 2b), markers of dividing precursors and of matured neurons,
respectively, in E16.5 crmp1 ⫺ / ⫺ mice, were not different from
those in crmp1 ⫹/ ⫺ mice (Fig. 1C,D). These results indicate that
CRMP1 plays a major role in neuronal cells at the postmitotic
phase.
We next investigated whether a Sema3A-CRMP1 signaling
cascade was also involved in neuronal migration in the cerebral
cortex. Because most of the sema3A ⫺ / ⫺ pups died after birth, we
performed only E18.5–BrdU–E14.5 analysis in the sema3A⫺/⫺
cortex. We did not observe any differences between wt,
sema3A ⫹/ ⫺, and sema3A ⫺ / ⫺ in the E18.5–BrdU–E14.5 cortices
(Fig. 2 A). In addition, double heterozygous crmp1 and sema3A
mice did not show any differences compared with crmp1 ⫹/ ⫺
mice in the E18.5–BrdU–E14.5, P10 –BrdU–E14.5, P3–BrdU–
E16.5, and P10 –BrdU–E16.5 cortices (Fig. 2 B, C) (data not
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Figure 1. Abnormally positioned neurons in the crmp1⫺/⫺ cerebral cortex. A, Distribution of cells in the P10 –BrdU–E14.5 crmp1 ⫹/ ⫺ or crmp1 ⫺ / ⫺ coronal cortical sections. The rate of the
BrdU-labeled nuclei of each bin (see Materials and Methods) is shown in b. B, Distribution of cells in the P10 –BrdU–E16.5 crmp1 ⫹/ ⫺ and crmp1 ⫺ / ⫺ coronal cortical sections. The rate of the
BrdU-labeled nuclei of each bin is shown in b. In all cases, three littermates of each genotype were used for quantification. C, E16.5 crmp1⫹/⫺ or crmp1⫺/⫺ coronal cortical sections immunostained
with anti-MAP-2 (2a ⫹ 2b) (a) and anti-Nestin (b) antibodies. D, Expression levels of MAP-2 (2a ⫹ 2b) and Nestin at E16.5 crmp1⫹/⫺ or crmp1⫺/⫺ mouse cortex lysates from two individual
embryos of each genotype. Equal amounts of protein were analyzed, as indicated by the loading control (␤-actin). Cortical layers are shown on the left. Scale bars: A, B, 100 m; C, 10 m. MZ,
Marginal zone; CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. *p ⬍ 0.05, **p ⬍ 0.01 compared with the corresponding value in crmp1⫹/⫺.

shown). These results suggest that CRMP1 mediates some signaling molecules other than Sema3A in cortical layer formation.
CRMP1 is involved in Reln signaling
In radial migration in the cerebral cortex, tyrosine phosphorylation of Dab1 by a Reln signaling cascade has been shown to be
essential. Biochemical analysis has revealed a decreased tyrosine
phosphorylation of Dab1 in the Relnrl/rl cortex (Howell et al.,
1999a, 2000). One of the tyrosine kinases that is involved in phosphorylation of Dab1 is Fyn, an Src-type tyrosine kinase (Bock and
Herz, 2003). Because we found that CRMP1 was tyrosine phosphorylated by Fyn in HEK293T cells (Fig. 3A), we assumed that
CRMP1 was one of the substrates phosphorylated by tyrosine
kinases through a Reln signaling cascade. To examine this hypothesis, we immunoprecipitated Relnrl/⫹ and Relnrl/rl brain lysates with anti-CRMP1 antibody and analyzed tyrosine phosphorylation levels of CRMP1 by anti-phospho-tyrosine
antibody. The phosphorylation of CRMP1 at tyrosine residue(s)
was detected in the brain lysate from Relnrl/⫹ mice. The level of
tyrosine phosphorylation of CRMP1 was decreased in the Relnrl/rl
cortex (Fig. 3B). The relative level of tyrosine phosphorylation of
CRMP1 in Relnrl/rl normalized by the amount of immunoprecipitated CRMP1 in Relnrl/⫹ (100.0 ⫾ 25.0) was 38.8 ⫾ 5.2% (N ⫽ 3;

p ⬍ 0.05). In addition, the expression of CRMP1 showed a higher
level in Relnrl/rl than in Relnrl/⫹ mice. The CRMP1 expression was
increased to a lesser extent than was the Dab1 expression in the
brain lysates from Relnrl/rl mice (Fig. 3C). The relative amount of
CRMP1 normalized by ␤-actin in Relnrl/⫹ and Relnrl/rl was
100.0 ⫾ 11.8 and 155.8 ⫾ 17.3%, respectively (N ⫽ 3; p ⬍ 0.05).
In Relnrl/rl cortex, reduced Dab1 expression is observed at superplate, whereas its increased expression is observed at cortical
plate (Rice et al., 1998). We examined the protein expression
pattern of CRMP1 in Relnrl/⫹ and Relnrl/rl cortices. Intense antiCRMP1 and Dab1 immunoreactivities were observed at the marginal zone in Relnrl/⫹ cortex, whereas reduced immunoreactivities were observed at superplate in Relnrl/rl cortex. In addition,
increased immunoreactivities of anti-CRMP1 and Dab1 at the
cortical plate were also observed in Relnrl/rl cortex. Increased
CRMP1 expression was observed in some neurons, whereas increased Dab1 expression was in almost all of the neurons of the
cortical plate in Relnrl/rl mice (Fig. 3D).
We further attempted to analyze the genetic interaction with
crmp1 and dab1; we used yotari mice, one of the spontaneous
mutants of dab1. Nissl staining of the brain at P10 revealed a
disrupted hippocampal lamination in the loss of crmp1 in a dab1
heterozygous background (crmp1 ⫺ / ⫺;dab1yot/⫹), one of the
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Discussion

Figure 2. Observation of BrdU birth-dating analysis in sema3A⫺/⫺ and sema3A⫹/⫺;
crmp1⫹/⫺ cortices. A, Distribution of cells in the E18.5–BrdU–E14.5 wt, sema3A⫹/⫺, and
sema3A ⫺ / ⫺ coronal cortical sections. MZ, Marginal zone; CP, cortical plate; IZ, intermediate
zone; SVZ, subventricular zone; VZ, ventricular zone. B, Distribution of cells in the P10 –BrdU–
E14.5 crmp1⫹/⫺ and crmp1⫹/⫺;sema3A⫹/⫺ coronal cortical sections. C, Distribution of cells
in the P10 –BrdU–E16.5 crmp1⫹/⫺ and crmp1⫹/⫺;sema3A⫹/⫺ coronal cortical sections. Cortical layers are shown on the left. Scale bar, 100 m.

Reeler-like phenotypes (Fig. 3E). This phenotype was not observed in crmp1 ⫺ / ⫺ and dab1yot/⫹ hippocampus (Fig. 3E) (Assadi et al., 2003), implying that CRMP1 and Dab1 were synergistically involved in Reln signaling for neuronal migration.

We provide, for the first time, evidence that CRMP1 is involved
in radial neuronal migration through Reln signaling in the developing cerebral cortex. In Relnrl/rl cortex, CRMP1 as well as Dab1,
an adaptor molecule in the transduction of the Reln signal, were
expressed at a higher level, yet these were tyrosine phosphorylated at a lower level. Loss of crmp1 in a dab1 heterozygous background led to the disruption of hippocampal lamination, a typical Reeler-like phenotype.
In the crmp1⫺/⫺ mouse cortex, retardation in neuronal migration was observed by BrdU birth-dating analysis when compared with the crmp1⫹/⫺ cerebral cortex (Fig. 1) (data not
shown). It is possible that Sema3A regulates neuronal migration
in the developing cerebral cortex. Indeed, Sema3A regulates the
tangential migration of GABAergic neurons from ganglionic eminence to the cerebral cortex (Marin et al., 2001; Tamamaki et al.,
2003). Expression of nrp1 and sema3A were also observed in the
cerebral cortex at E16.5 (Kawakami et al., 1996; Skaliora et al.,
1998). However, it appears that Sema3A signaling is not involved
in radial migration during the period of cortical layer formation,
because the retarded phenotype in radial neuronal migration was
not seen in either the sema3A⫺/⫺ or double heterozygotes of
crmp1 and sema3A mouse cortices (Fig. 2). Consistently, the
overall expression pattern of nrp1 was different from that of
crmp1 in the cerebral cortex at E16.5 (N. Yamashita, A. Morita, Y.
Uchida, F. Nakamura, H. Usui, M. Taniguchi, J. Honnorat, P.
Kolattukudy, N. Thomasset, K. Takei, T. Takahashi, and Y. Goshima, unpublished observations).
In contrast, the expression pattern of crmp1 was similar to that
of dab1. We clearly showed that the expression of CRMP1 was
increased in the Relnrl/rl cortex and reduced tyrosine phosphorylation of CRMP1 (Fig. 3 B, C). Furthermore, the protein expression pattern of CRMP1 was also similar to that of Dab1 at the
marginal zone and the cortical plate. The expression level of
CRMP1 was decreased at superplate and increased at the cortical
plate in the Relnrl/rl cortex, respectively (Fig. 3D). In adult Relnrl/rl
cerebellum, the number of granule cells was reduced, and transient reduction of granule cells was observed in crmp1⫺/⫺ cerebellum (Rice et al., 1998; Charrier et al., 2006). We found that loss
of crmp1 in a dab1 heterozygous background led to the disruption
of hippocampal lamination, a Reeler-like phenotype (Fig. 3E).
Because the mutations in Reln pathway genes cause distinctive
abnormalities in many laminated brain regions, known as the
Reeler phenotype (D’Arcangelo et al., 1999; Hiesberger et al.,
1999; Howell et al., 1999b), these findings strongly suggest that
CRMP1 mediates Reln signaling to regulate neuronal migration.
We assumed that Reln regulates neuronal migration through
tyrosine phosphorylation of CRMP1 because decreased tyrosine
phosphorylation of Dab1 is observed in the Relnrl/rl cortex (Howell et al., 1999a, 2000), and animals expressing the nonphosphorylated Dab1 protein have a phenotype similar to the dab1 null
mutant (Howell et al., 2000). Fyn and Fes tyrosine kinases have
also been proposed to be signaling components of Sema3A (Mitsui et al., 2002; Sasaki et al., 2002). We found that when CRMP1
and Fyn were introduced into HEK293T cells, CRMP1 was phosphorylated at tyrosine residue(s) (Fig. 3A). We tried to detect
phosphorylation of CRMP1 at tyrosine residue(s) in the cultured
cortical neurons treated with Reln. Up to now, we have not yet
obtained clear evidence for tyrosine phosphorylation of CRMP1
after Reln stimulation. The important finding is, however, that
the level of tyrosine phosphorylation of CRMP1 was decreased in
the Relnrl/rl cortex (Fig. 3B). Additional studies are required to
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delineate phosphorylation site(s) of
CRMP1 and its functional significance in
Reln signaling.
The presence of Reln correlates with reduced Dab1 protein levels during embryonic development (Rice et al., 1998; Howell et al., 1999a). Our study showed that the
expression of CRMP1 was higher in
Relnrl/rl cortex compared with Relnrl/⫹
mice (Fig. 3C), suggesting that Reln regulates CRMP1 protein levels in the cerebral
cortex. This further indicates that CRMP1
possesses a biochemical property similar
to Dab1. Interestingly, some neurons exhibited an increased immunoreactivity of
CRMP1 in the Relnrl/rl cortical plate at
E16.5, whereas Dab1 accumulation was
observed in almost all neurons in the cortical plate (Fig. 3D). This result suggests
that CRMP1 may regulate migration of a
subset of the cortical neurons. The neurons exhibiting increased immunoreactivity of CRMP1 in the Relnrl/rl cortex were
distributed throughout the cerebral cortex
(Fig. 3D). Consistent with this observation, crmp1⫺/⫺ showed a retarded migration phenotype in both the upper and deep
layers of the cerebral cortex (Fig. 1 A, B).
These findings suggest that neurons in
which CRMP1 may regulate their migration are composed of a heterogeneous subpopulation, being unrelated to a specific
cortical layer. The characterization of the
CRMP1-positive neurons remains to be
determined. The expression pattern of another CRMP family member, crmp2, was
almost similar to that of crmp1 (Wang
and Strittmatter, 1996). Both CRMP1 and
CRMP2 are involved in mediating
Sema3A signaling (Uchida et al., 2005).
These findings are consistent with a mild
defect in neuronal migration in the
crmp1 ⫺/⫺ cortex, rather than in the
Relnrl/rl cerebral cortex. Indeed, disruption
of a single gene, having overlapping func4

Figure 3. Expression and tyrosine phosphorylation of CRMP1 in Relnrl/rl cortex and the genetic interaction between crmp1 and
dab1 in the hippocampus. A, Tyrosine phosphorylation of CRMP1 by Fyn. CRMP1-Myc was introduced with or without the
wild-type (WT), constitutive-active (CA), or dominant-negative (DN) form of Fyn in HEK293T cells. Immunoprecipitation with
anti-Myc antibody was performed and was thereafter immunoblotted with anti-p-Tyr and anti-Myc antibodies. B, Tyrosine
phosphorylation of CRMP1 in Relnrl/⫹ and Relnrl/rl lysates from mouse cortex at E16.5. Immunoprecipitation with anti-CRMP1

antibody was performed and was thereafter immunoblotted
with anti-p-Tyr and anti-CRMP1 antibodies. C, Expression
levels of CRMP1 at E16.5 Relnrl/⫹ and Relnrl/rl brain lysates.
Immunoblot analysis of anti-CRMP1 and anti-Dab1 antibodies of three individual embryos of each genotype was
performed. Equal amounts of protein were analyzed, as indicated by the loading control (␤-actin). D, Immunohistochemistry with anti-CRMP1 (magenta) and anti-Dab1
(green) antibodies in E16.5 Relnrl/⫹ (a– c) and Relnrl/rl (d–f )
coronal cortical sections. Cortical layers are shown on the left.
MZ, Marginal zone; CP, cortical plate; SPP, superplate. E, Nissl
staining of the brains at P10 of crmp1 ⫺ / ⫺ (a, d),
crmp1 ⫺ / ⫺;dab1yot/⫹ (b, e), and crmp1 ⫺ / ⫺;dab1yot/yot
(c, f ) mice. Coronal sections of the hippocampus region are
presented. Magnified images of the CA1 region in a, b, and c
are shown in d, e, and f, respectively. Scale bars: D, 10 m; E,
100 m.
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tions, sometimes does not result in any phenotypic defects in the
mutant animals (Kuo et al., 2005). The combined disruption with
other CRMP family genes will therefore tell us the exact roles of
CRMP1 in the developing cerebral cortex.
This is the first evidence for an important role of CRMP1 in
Reln signaling. It appears that the CRMP family is involved in
cytoskeletal organization by receiving various extracellular cues
that contribute to neuronal development and maturation.
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